NASDAQ:BGNE - BeiGene, Ltd.
$119.80
 $-1.23
-1.02%
4:00PM EDT
2019-04-18
BeiGene, Ltd. is a clinical-stage biopharmaceutical company. The Company is focused in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The Company had used its cancer biology platform to develop four clinical-stage drug candidates, such as BGB-3111, BGB-A317, BGB-290 and BGB-283, as of December 31, 2016. BGB-3111, BGB-290 and BGB-283 are its molecularly targeted agents and is its immuno-oncology agent. BGB-3111 is a potent and highly selective small molecule inhibitor of Bruton's tyrosine kinase (BTK). BGB-283 is a molecule inhibitor of both the monomer and dimer forms of the RAF kinase. BGB-290 is a molecularly targeted, orally available, potent and highly selective inhibitor of the poly ADP ribose polymerase (PARP) family members. BGB-A317 is an investigational humanized monoclonal antibody against the immune checkpoint receptor, PD-1. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  BGNE     avg for
industry  
  avg for
sector  
42 stocks weight:  325. 09   199. 07   233. 87  
42 stocks rank:  478. 00   1. 43 K 1. 06 K
# analyst opinions:  10. 00   14. 48   14. 09  
mean recommendation:  1. 60   2. 09   2. 01  

quick ratio:  7. 44   5. 29   1. 92  
current ratio:  7. 89   5. 64   2. 40  

target price low:  168. 20   84. 50   115. 74  
target price avg:  190. 82   110. 73   137. 39  
target price high:  214. 00   136. 41   157. 80  
1-yr high:  216. 77   114. 11   138. 85  
last close:  119. 80   87. 56   116. 78  
50-day avg:  136. 00   95. 43   123. 53  
200-day avg:  144. 73   94. 13   121. 20  
1-yr low:  107. 01   72. 67   98. 41  
volume:  428. 62 K 2. 43 M 4. 85 M
50-day avg volume:  291. 29 K 2. 72 M 4. 97 M
200-day avg volume:  399. 96 K 2. 90 M 4. 58 M

1-day return:  -1. 02 % -0. 40 % 0. 07 %
this week return:  -7. 92 % -5. 72 % -4. 11 %
12-wk return:  -5. 02 % 1. 78 % -0. 04 %
52-wk return:  -16. 70 % 10. 81 % 14. 09 %

enterprise value (EV):  6. 20 B 51. 19 B 117. 96 B
market cap:  7. 14 B 43. 00 B 104. 52 B
EBITDA:  -695. 38 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -8. 91   4. 34   13. 27  
enterprise/revenue (EV/R):  31. 26   68. 16   13. 68  
total revenue:  198. 22 M 10. 61 B 38. 24 B
total debt:  198. 40 M 12. 22 B 16. 66 B
debt/equity:  11. 31   46. 86   89. 46  
net income (common):  -673. 77 M 2. 20 B 4. 21 B

shares outstanding:  59. 63 M 570. 91 M 1. 24 B
shares:  32. 10 M 571. 02 M 1. 23 B
shares short:  3. 81 M 9. 93 M 16. 79 M
shares short prior month:  3. 50 M 9. 96 M 16. 58 M
short ratio:  14. 35   5. 31   3. 30  
total cash/share:  29. 85   11. 13   9. 30  
total cash:  1. 78 B 6. 70 B 7. 10 B
free cash flow:  -479. 80 M 3. 58 B 4. 74 B
operating cash flow:  -547. 72 M 4. 14 B 6. 32 B

book value:  29. 14   12. 76   26. 84  
price/book:  4. 11   3. 08   -1. 74  
gross profits:  169. 51 M 8. 03 B 34. 77 B
operating margins:  -356. 05 % -721. 97 % -88. 82 %
EBITDA margins:  0. 00 % 10. 94 % 22. 54 %
profit margins:  0. 00 % 7. 81 % 10. 60 %
gross margins:  -257. 03 % 37. 02 % 55. 68 %

1-yr max volatility:  13. 78 % --- ---
1-yr mean volatility:  -0. 08 % 0. 03 % 0. 04 %

1-yr EPS:  -12. 15   2. 39   4. 08  
forward EPS:  -12. 63   3. 97   7. 14  
P/E:  -9. 86   13. 59   22. 83  
forward P/E:  -10. 30   -20. 05   14. 49  
PE/G:  -0. 04   -1. 46   1. 68  
growth:  222. 80 % 126. 81 % 29. 29 %
earnings high:  -2. 38   1. 02   1. 63  
earnings avg:  -3. 57   0. 76   1. 51  
earnings low:  -5. 01   0. 47   1. 39  
revenue high:  67. 30 M 2. 68 B 10. 71 B
revenue avg:  56. 98 M 2. 59 B 10. 49 B
revenue low:  40. 00 M 2. 49 B 10. 25 B
return on assets:  -26. 77 % -2. 80 % 5. 29 %
return on equity:  -55. 30 % -18. 52 % 7. 38 %
revenue growth:  222. 80 % 92. 55 % 19. 15 %
revenue/share:  3. 58   13. 27   55. 24  

beta (1yr vs S&P500):  1. 57   1. 24   0. 93  
sharpe (1yr):  -0. 40   0. 29   0. 60  

held % insiders:  0. 03 % 6. 38 % 3. 38 %
held % institutions:  88. 60 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : BGNE
.        + 0 =             0 :: INITIAL WEIGHT
.   + 30.061 =        30.061 :: inverse volume-to-price addition
.   + 47.774 =        77.835 :: spline projection addition
.    x 1.656 =       128.906 :: 13 weeks' performance factor
.    x 0.827 =       106.657 :: one-year gains+dividend factor
.    x 1.432 =       152.736 :: industry recommendation factor
.    x 2.982 =        455.53 :: symbol recommendation factor
.    x 1.459 =        664.41 :: EV/R factor
.    x 0.997 =       662.632 :: return on assets factor
.    x 0.994 =       658.968 :: return on equity factor
.    x 2.406 =      1585.647 :: revenue growth factor
.    x 2.601 =      4124.616 :: current ratio factor
.    x 1.075 =      4433.207 :: quick ratio factor
.    x 1.034 =      4585.073 :: short ratio factor
.    x 2.041 =      9358.666 :: price-to-book factor
.    x 1.114 =     10427.314 :: debt-to-equity factor
.    x 1.983 =      20679.47 :: P/E weight
.     x 2.18 =     45089.443 :: PE/G factor
.    x 1.368 =     61694.207 :: beta factor
.    x 0.395 =     24399.406 :: sharpe factor
.    x 1.675 =     40872.386 :: target low factor
.    x 1.257 =     51362.269 :: target mean factor
.    x 1.089 =     55916.774 :: target high factor
.    x 1.312 =     73343.147 :: industry 2-weeks return factor
.    x 0.915 =      67096.89 :: "drift" penalty 1 days ago
.    x 0.918 =     61619.332 :: "drift" penalty 4 days ago
.    x 0.995 =     61325.391 :: overall "drift" factor
.    x 0.862 =      52876.46 :: largest single-day jump factor
.     x 1.01 =     53404.789 :: mean volatility factor
.    x 1.098 =     58621.195 :: 42-day mean volatility factor
.      x 1.0 =     58611.746 :: factor hist industry gain for week 15
.   cubeRoot =        38.844 :: reduced to standardize
.  + 286.249 =       325.094 :: add/subtract for performance
.                    325.094 :: FINAL WEIGHT for NASDAQ:BGNE


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org